Exact Mass: 358.262
Exact Mass Matches: 358.262
Found 500 metabolites which its exact mass value is equals to given mass value 358.262,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pregnenolone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
11beta-Hydroxy-6alpha,11-dimethylprogesterone
D-Homotestosterone propionate
MG(18:0/0:0/0:0)
MG(18:0/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups: 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(18:0/0:0/0:0), in particular, consists of one chain of stearic acid at the C-1 position. MG(18:0/0:0/0:0 is used as a food additive (EAFUS: Everything Added to Food in the United States). MG(18:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(18:0/0:0/0:0) is made up of one octadecanoyl(R1).
MG(0:0/18:0/0:0)
MG(0:0/18:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(0:0/18:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/18:0/0:0) is made up of one octadecanoyl(R2).
MG(i-18:0/0:0/0:0)
MG(i-18:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(i-18:0/0:0/0:0) is made up of one 16-methylheptadecanoyl(R1).
Kinetensin 1-3
Kinetensin 1-3 is a fraction of kinetensin with only the Ile-Ala-Arg peptide chain. Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma that shares some sequence homology with the C-terminal end of neurotensin, serum albumin, and angiotensin. It is a potent histamine releaser in rodents and may serve as an inflammatory mediator. Kinetensin 1-3 is a fraction of Kinetensin with only Ile-Ala-Arg peptide chain.
13,14-Dihydro PGF-1a
13,14-Dihydro PGF-1alpha is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207) [HMDB] 13,14-Dihydro PGF-1alpha is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207).
Tetracosapentaenoic acid (24:5n-6)
Tetracosapentaenioc acid is intermediate of Linolenic acid metabolism. [HMDB] Tetracosapentaenioc acid is intermediate of Linolenic acid metabolism.
Tetracosapentaenoic acid (24:5n-3)
Tetracosapentaenioc acid is intermediate of alpha-Linolenic acid metabolism. [HMDB] Tetracosapentaenioc acid is intermediate of alpha-Linolenic acid metabolism.
1-Phenyl-1,3-octadecanedione
1-Phenyl-1,3-octadecanedione is found in fats and oils. 1-Phenyl-1,3-octadecanedione is a constituent of the pollen of Helianthus annuus (sunflower) Constituent of the pollen of Helianthus annuus (sunflower). 1-Phenyl-1,3-octadecanedione is found in fats and oils.
24,25,26,27-Tetranor-23-oxo-hydroxyvitamin D3
This compound belongs to the family of Steroids and Steroid Derivatives. These are compounds based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred.
MG(0:0/i-18:0/0:0)
MG(0:0/i-18:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/i-18:0/0:0) is made up of one 16-methylheptadecanoyl(R2).
Testosterone isobutyrate
16,17,18,20-Tetrahydroxy-10,11,14,15-tetrahydronerylgeraniol
(3alpha,14beta)-14,16-epoxy-3,18-[(1-methylethane-1,1,diyl)dioxy]-ent-abieta-7,15(17)-diene-14,16-diol
rel-(2S,4R)-2,4-dimethyl-4-hydroxy-16-phenylhexadecanoic acid 1,4-lactone
(-)-Ochropposinine|10,11-dimethoxy-corynan-17-ol|ochroposinine|Ochropposinin|ochropposinine
Hexadecanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester
16,17,15,20-tetrahydrosecodin-17-ol|Tetrahydrosecodin-17-ol|Tetrahydrosecodinol
3,17-dimethyl-18,19-dinor-17alpha-cholesta-1,3,5,7,9,11,13-heptaene
(3beta,5beta,14beta)-14,21-epoxy-24-norcholan-20,22-diene-3,5-diol
(3S*,3aR*,5aR*,6S*,8aR*,11bS*,11cS*)-2,3,3a,5,5a,6,7,8,8a,9,10,11c-dodecahydro-5a-(hydroxymethyl)-3-methyl-1,6-methano-1H-azuleno[5,4-g]indole-11b(4H)-propanamide|macropodumine I
2-alpha-acetyloxy-5-alpha-pregn-17(20)-(cis)-en-16-one
(Z)-1-(4-hydroxyphenyl)octadec-13-en-5-one|3,14-Didehydro(Z)-1-(4-Hydroxyphenyl)-5-octadecanone
(3beta,5alpha)-3-Hydroxy-4,4,14-trimethylpregn-8-en-20-one
agallochin C|ent-15-chloro-labd-8(9)-en-3alpha,13,14-triol
3-[2-butyl-1-[2-(diethylamino)ethyl]-5-benzimidazolyl]-N-hydroxy-2-propenamide
(9S,10R,13R,14S,17R)-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
Ala Ala Val Val
Ala Gly Ile Val
Ala Gly Leu Val
Ala Gly Val Ile
Ala Gly Val Leu
Ala Ile Gly Val
Ala Ile Val Gly
Ala Leu Gly Val
Ala Leu Val Gly
Ala Val Ala Val
Ala Val Gly Ile
Ala Val Gly Leu
Ala Val Ile Gly
Ala Val Leu Gly
Ala Val Val Ala
Gly Ala Ile Val
Gly Ala Leu Val
Gly Ala Val Ile
Gly Ala Val Leu
Gly Gly Ile Ile
Gly Gly Ile Leu
Gly Gly Leu Ile
Gly Gly Leu Leu
Gly Ile Ala Val
Gly Ile Gly Ile
Gly Ile Gly Leu
Gly Ile Ile Gly
Gly Ile Leu Gly
Gly Ile Val Ala
Gly Leu Ala Val
Gly Leu Gly Ile
Gly Leu Gly Leu
Gly Leu Ile Gly
Gly Leu Leu Gly
Gly Leu Val Ala
Gly Val Ala Ile
Gly Val Ala Leu
Gly Val Ile Ala
Gly Val Leu Ala
Ile Ala Gly Val
Ile Ala Val Gly
Ile Gly Ala Val
Ile Gly Gly Ile
Ile Gly Gly Leu
Ile Gly Ile Gly
Ile Gly Leu Gly
Ile Gly Val Ala
Ile Ile Gly Gly
Ile Leu Gly Gly
Ile Val Ala Gly
Ile Val Gly Ala
Leu Ala Gly Val
Leu Ala Val Gly
Leu Gly Ala Val
Leu Gly Gly Ile
Leu Gly Gly Leu
Leu Gly Ile Gly
Leu Gly Leu Gly
Leu Gly Val Ala
Leu Ile Gly Gly
Leu Leu Gly Gly
Leu Val Ala Gly
Leu Val Gly Ala
Val Ala Ala Val
Val Ala Gly Ile
Val Ala Gly Leu
Val Ala Ile Gly
Val Ala Leu Gly
Val Ala Val Ala
Val Gly Ala Ile
Val Gly Ala Leu
Val Gly Ile Ala
Val Gly Leu Ala
Val Ile Ala Gly
Val Ile Gly Ala
Val Leu Ala Gly
Val Leu Gly Ala
Val Val Ala Ala
PGF2alpha-d4
13,14-DIHYDRO PROSTAGLANDIN F1ALPHA
tetranor-23-oxo-1alpha(OH)D3
ascr#21
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,12R)-12-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#21
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-13-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
Amidonal
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators
3-stearoyl-sn-glycerol
A 3-acyl-sn-glycerol that has octadecanoyl (stearoyl) as the 3-acyl group.
Butanedioic acid,2-hydroxy-, 1,4-bis(2-ethylhexyl) ester
1-(tert-butyldimethylsilyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine
ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER
1-(1-ADAMANTYL)-3-(2,4,6-TRIMETHYLPHENYL)-4,5-DIHYDROIMIDAZOLIUM CHLORIDE
tert-butyl 4-(3-ethyl-3-methyl-2-oxoindol-1-yl)piperidine-1-carboxylate
(1S,2S,3S,4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester
2,2’-(2,5-Dimethyl-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
1,1,5-trimethyl-3,3-bis(2-methylpentan-2-ylperoxy)cyclohexane
Thiourea, N-cyclopentyl-N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-propyl- (9CI)
Bis-(2-Methyl-benzyl)-piperidin-2-ylMethyl-aMine hydrochloride
5-ethyl-2-methylidenenonanoic acid,methyl propanoate,prop-2-enoic acid
3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-benzoyl-, 1,1-dimethylethyl ester
(2E,12R)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid
16-Butyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol
Silane, [[3,7-dimethyl-9-(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-3,5,7-nonatrienyl]oxy]trimethyl-
17beta-Hydroxy-7alpha-methylandrost-4-en-3-one propionate
Pracinostat
C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(2E)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid
(3-Carboxy-2-tridecanoyloxypropyl)-trimethylazanium
[3-carboxy-2-[(Z)-3-hydroxydodec-9-enoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-(5-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(6-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(7-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(11-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(8-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(4-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(10-methyldodecanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(9-methyldodecanoyloxy)propyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-8-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-3-hydroxydodec-4-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-3-hydroxydodec-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-3-hydroxydodec-8-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-5-hydroxydodec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-7-hydroxydodec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-8-hydroxydodec-10-enoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-(3-oxododecanoyloxy)propyl]-trimethylazanium
Leu-Leu-Asn
A tripeptide composed of two L-leucine units joined to L-asparagine by a peptide linkage.
((2,2-Dimethyl-3-vinyl-2H-chromen-7-yl)oxy)triisopropylsilane
Ethyl {(1s,4s,5s)-4-[(isonicotinoylamino)methyl]-5-isopropyl-2-methyl-2-cyclohexen-1-yl}acetate
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
6,7-dimethoxy-N,N-dipropyl-2-(1-pyrrolidinyl)-4-quinazolinamine
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
[(2R)-3-carboxy-2-tridecanoyloxypropyl]-trimethylazanium
[(2R)-3-carboxy-2-tridecanoyloxypropyl]-dimethyl-(trideuteriomethyl)azanium
(1-Hydroxy-3-propanoyloxypropan-2-yl) tetradecanoate
(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoic acid
A very long-chain omega-3 fatty acid that is tetracosanoic acid having five double bonds located at positions 9, 12, 15, 18 and 21 (the (9Z,12Z,15Z,18Z,21Z-isomer).
(6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoic acid
A very long-chain omega-6 fatty acid that is tetracosanoic acid having five double bonds located at positions 6, 9, 12, 15 and 18 (the 6Z,9Z,12Z,15Z,18Z-isomer).
12-hydroxy-4b,7,7,10a,12a-pentamethyl-3,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-2-carbaldehyde
4a,6a,7-trimethyl-1h,2h,3h,4h,4bh,5h,6h,6bh,7h,8h,9h,10h,11h,11ah,11bh,12h-indeno[2,1-a]phenanthrene-2,10a-diol
(1s,6r,8s,11s,12r,15s,16s,19s,21s)-19-methoxypentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-ol
(1e,3as,3br,5as,7r,9as,9bs,11as)-1-ethylidene-9a,11a-dimethyl-2-oxo-dodecahydro-3h-cyclopenta[a]phenanthren-7-yl acetate
8-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-2,6-dimethylocta-3,5-dienoic acid
(1r,5r,6r)-4-ethyl-5-hydroxy-1-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-one
(2s,5r,6r,10r,13s,14r)-13-acetyl-2,5,10,14-tetramethyltetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-1(9)-ene-5-carboxylic acid
16-(dimethylamino)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-7-ol
(1r,3as,3bs,4s,7r,9ar,9bs,11ar)-1-ethenyl-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
3-hydroxypregn-17(20)-en-16-one; (3α,5α,17(20)e)-form,ac
{"Ingredient_id": "HBIN008743","Ingredient_name": "3-hydroxypregn-17(20)-en-16-one; (3\u03b1,5\u03b1,17(20)e)-form,ac","Alias": "NA","Ingredient_formula": "C23H34O3","Ingredient_Smile": "NA","Ingredient_weight": "358.51","OB_score": "NA","CAS_id": "166901-88-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8072","PubChem_id": "NA","DrugBank_id": "NA"}
agallochin c
{"Ingredient_id": "HBIN014804","Ingredient_name": "agallochin c","Alias": "NA","Ingredient_formula": "C20H35ClO3","Ingredient_Smile": "CC1=C(C2(CCC(C(C2CC1)(C)C)O)C)CCC(C)(C(CCl)O)O","Ingredient_weight": "358.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "686","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15543015","DrugBank_id": "NA"}
